Osteoporosis Drugs Market Analysis: Forecast and Key Insights for 2024-2031 | Most Leading Companies - F. Hoffmann-La Roche, Novartis AG, Merck & Co, Pfizer, Eli Lilly and Co. (Lilly), Amgen Inc

The Global Osteoporosis Drugs Market reached US$ 14,066.4 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 19,336.6 million by 2031. The global osteoporosis drugs market is expected to exhibit a CAGR of 4.1% during the forecast period (2024-2031).

Osteoporosis Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/osteoporosis-drugs-market?kb

Osteoporosis drugs are medications designed to strengthen bones, reduce fracture risk, and increase bone mineral density (BMD) in individuals with osteoporosis. These drugs typically target bone resorption or stimulate bone formation to help maintain bone health, especially in those who are at high risk for fractures due to weakened bones.

List of the Key Players in the Osteoporosis Drugs Market:

F. Hoffmann-La Roche, Novartis AG, Merck & Co, Pfizer, Eli Lilly and Co. (Lilly), Amgen Inc., Radius Health, Teva Pharmaceutical Industries, GSK and AbbVie among others.

Industry Development:

In May 2023, Transcenta Holding Limited, a clinical-stage biopharmaceutical company specializing in antibody-based therapeutics, reported promising phase I clinical results of TST002 (Blosozumab) in Chinese patients with low bone mineral density (BMD). Following a single intravenous injection at varying doses, TST002 significantly increased BMD by day 85 and was well tolerated.

In May 2023, a real-world study involving nearly half a million postmenopausal women with osteoporosis enrolled in the U.S. Medicare program revealed that Prolia (denosumab) injection significantly reduced fracture risk compared to oral alendronate, a widely used bisphosphonate. Over time, Prolia was also associated with a notable reduction in fracture risk.

Research Process:

Both primary and secondary data sources have been used in the global Osteoporosis Drugs Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/osteoporosis-drugs-market?kb

Segment Covered in the Osteoporosis Drugs Market:

By Drug Class: Bisphosphonates, RANK Ligand Inhibitors, Selective Estrogen Receptor Modulators, Parathyroid Hormone Analog, Strontium, Calcitonin, Anti-Sclerostin, and Cathepsin K Inhibitor

By Product Type: Branded and Generics

By Distribution Channel: Hospital Pharmacy, Retail Pharmacy and Other

Regional Analysis for Osteoporosis Drugs Market:

The regional analysis of the Osteoporosis Drugs Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/osteoporosis-drugs-market?kb

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Osteoporosis Drugs market?

➠ Who are the leading manufacturers in the global Osteoporosis Drugs industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Osteoporosis Drugs industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Osteoporosis Drugs market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.